TODAY -

COVAXIN® Phase III data published in The Lancet

Hyderabad, November 12, 2021



Bharat Biotech, a global leader in vaccine development and innovation, announced today that the safety and efficacy analysis data from Phase III clinical trials of COVAXIN® is peer reviewed and published in The Lancet.

The Lancet peer-review confirms the efficacy analysis which demonstrates COVAXIN® to be effective against COVID-19. COVAXIN®is the only COVID-19 vaccine to have demonstrated efficacy data from phase III clinical trials against the delta variant at 65.2%.

o Efficacy analysis demonstrates COVAXIN® to be 77.8% effective against symptomatic COVID-19, through evaluation of 130 confirmed cases, with 24 observed in the vaccine group versus 106 in the placebo group

o Efficacy analysis demonstrates COVAXIN® to be 93.4% effective against severe symptomatic COVID-19

o Safety analysis demonstrates adverse events reported were similar to placebo, with 12% of subjects experiencing commonly known side effects and less than 0.5% of subjects experiencing serious adverse events

o Efficacy data demonstrates 63.6% protection against asymptomatic COVID-19

o Efficacy data demonstrates 65.2% protection against the SARS-CoV-2, B.1.617.2 Delta

o Efficacy data demonstrates 70.8% protection against all variants of SARS-CoV-2 virus

COVAXIN® was developed under a partnership with the Indian Council of Medical Research and the National Institute of Virology, with Bharat Biotech receiving the SARS-COV-2 strains through this collaboration.

Bharat Biotech had established an ongoing collaboration with ViroVax since 2019, through the Indo-U.S. Vaccine Action Program, to develop and evaluate IMDG (Alhydroxiquim-II), a novel TLR7/8 agonist molecule, which is formulated as part of the adjuvant in COVAXIN®. The Adjuvant Program of the U.S. National Institute of Allergy and Infectious Diseases (NIAID) has supported ViroVax since 2009.

Dr. Krishna Ella, CMD, Bharat Biotech, said, “The peer-review of COVAXIN® phase III clinical trial data in The Lancet, an authoritative voice in global medicine validates our commitment to data transparency and meeting the stringent peer-review standards of world leading medical journals.

The data from our product development and clinical trials have been published in 10 peer-reviewed journals, making COVAXIN® one of the most highly published COVID-19 vaccines in the world.

This accomplishment reflects the undeterred commitment by my team members at Bharat Biotech, our public partners, Indian Council of Medical Research, National Institute of Virology, and the trust imposed by our trial participants who made this happen.”

The phase 3 trial Efficacy and Safety Study involving 25,800 volunteers across 25 sites in India is India’s largest ever clinical trial conducted for a Covid-19 vaccine.

COVAXIN® was well tolerated and the Data Safety Monitoring Board has not reported any safety concerns related to the vaccine. The overall rate of adverse events observed in COVAXIN® was lower than that seen in Covid-19 vaccines. The safety profile of COVAXIN® is now well established based on inactivated vaccines technology, and in large part due to the extensive 25-year safety track record of Bharat Biotech’s vero cell manufacturing platform.

Dr. Balram Bhargava, Director General, Indian Council of Medical Research (ICMR), said, “Following successful isolation of the SARS-CoV-2 virus at ICMR -National Institute of Virology (NIV), Pune, ICMR and Bharat Biotech International Ltd (BBIL) embarked upon one of the most successful public-private partnership to develop the virus isolate into an effective COVID-19 vaccine. I am delighted to see that the phase III efficacy data has also been published in THE LANCET, one of the most reputed journals worldwide.

This itself speaks high about the strong position of COVAXIN® amongst other global front-runners COVID-19 vaccines. The bench to bedside journey of COVAXIN® in less than 10 months showcases the immense strength of “Atmanirbhar Bharat” along with the Indian academia and industry in fighting against the odds and carving a niche in the global community.”

Recently, the World Health Organization granted emergency use listing to COVAXIN® enabling countries to expedite their regulatory approval to import and administer doses. It has also received emergency use authorizations in several countries with applications in process in more than 50 countries worldwide. Bharat Biotech has partnered with Ocugen to obtain approvals for COVAXIN® in the United States and Canada.

With more than 150 million doses manufactured, supplied, and with an excellent safety and efficacy profile, COVAXIN®is a major contributor to the global fight against the COVID-19 pandemic.

COVAXIN®is currently being evaluated in controlled clinical trials in children 2-18 years of age, with results available during Q4 2021.

Bharat Biotech is poised to achieve its goal of an annualized capacity of ~1.0 billion doses of COVAXIN® by the end of 2021.


* This Press Release was sent to e-pao.net by Rooplin Sharma who can be contacted at sharma(DOT)rooplin(AT)gmail(DOT)com
This Press Release was posted on 13 November 2021

* Comments posted by users in this discussion thread and other parts of this site are opinions of the individuals posting them (whose user ID is displayed alongside) and not the views of e-pao.net. We strongly recommend that users exercise responsibility, sensitivity and caution over language while writing your opinions which will be seen and read by other users. Please read a complete Guideline on using comments on this website.




LATEST IN E-PAO.NET
  • Celebrate festival with Covid protocol
  • COVID-19 Status 26 Nov : Govt of Manipur
  • Featured Front Page Photo 2021 #5: Gallery
  • COVID-19 : Impact in Manipur :: News Timeline
  • Constitution Day at Lilong
  • Constitution Day at Lamphel Court
  • Applicants : Manipur Entrepreneurs Society
  • Executive Committee posts for YMC
  • Transgenders : Struggling for identity
  • Anthelmintic resistance: Havoc to veterinary
  • Signing pacts hallmark policy to delay stir
  • Paddy land conservation
  • Jiribam Keithel [Sept 2021] #1 : Gallery
  • COVID-19 Status 25 Nov : Govt of Manipur
  • Time heals
  • Manipur women : Champions Sepak Takraw
  • TEDxYouth@RonaldsayRoad at Agartala
  • Tips to make nail paint last longer
  • Health Min data exposes Govt inefficiency
  • Leaving out Manipur from the loop?
  • RIMS, Lamphel, Imphal #2 : Gallery
  • COVID-19 Status 24 Nov : Govt of Manipur
  • COVID-19 Status 23 Nov : Govt of Manipur
  • Activism Against Gender based Violence
  • National Lok Adalat at Lamphel
  • MPSC cleaning by LAC
  • Hope - the essence of life
  • Students Induction Programme at Lilong
  • Ending cash-for-vote trend a pipedream
  • Pluralistic Manipur & divergent forces
  • Remembering Guru Gourkishwor Sharma
  • Training on mushroom cultivation : Gallery
  • What if TB, HIV medicines stop working?
  • NPF Women Wing Co-ordination meeting
  • World Children's Day
  • Pure passion :: Poem
  • Emergence of NPP in region's politics
  • Taking NE on board
  • Trekking @ Mount Koubru #2 : Gallery
  • Healthcare not handcuffs
  • Asymmetrical Federalism in North-East
  • Dr Konica Khuraijam- Best Educator-2021
  • Webinar : Relations betn India &SE Asia
  • Career as a Product Manager
  • Starting & ending with economic blockade!
  • ST : Renewed campaign & Govt's silence
  • Exposure visit to Kwatha by MTU
  • COVID-19 Status 21 Nov : Govt of Manipur
  • Sustainable Development at Noney
  • Nine Hills One Valley : World premier
  • Rs 3,30,000/- as assistance to journalists
  • Taj by night!
  • Boost for local handloom & handicraft
  • Drug smuggling from/through Manipur
  • Ningol Chakouba Shopping #2 : Gallery
  • COVID-19 Status 20 Nov : Govt of Manipur
  • 'AirOThon' for Manipur & Sikkim
  • Environment & antimicrobial resistance
  • A lone night traveller :: Poem
  • Central Govt finally bows to kisans
  • Mera Houchongba @ Kangla #3 : Gallery
  • COVID-19 Status 19 Nov : Govt of Manipur
  • Improving public transport will reduce pollution
  • Nutrition- Tool for resilience in COVID
  • Take a relook at NEET
  • Glorifying toothless ILP system in state
  • Lapses in ILPS: Complete let-down
  • Cultural Fest @Changangei #2: Gallery
  • COVID-19 Status 18 Nov : Govt of Manipur
  • Child Development Manager @ MaolKeki
  • Irujdn hEbi tEbi lMdM :: Seireng
  • The Killing Fields (2013-21) :: News Timeline
  • Is "to be like a girl" an insult?
  • Aloe vera for acne
  • Elections: Plentiful issues, solution minimal
  • Flawed education system & private tuition
  • National Press Day @DIPR : Gallery
  • Book review of Ikigai
  • Free Filmmaking Workshop at Guwahati
  • World Piles Day Colorectal Cancer
  • Diwali with a void
  • Heartache for loyal BJP ticket seekers
  • MPSC: Time for complete overhaul
  • Ningol Chakouba @ Delhi : Gallery
  • COVID-19 Status 16 Nov : Govt of Manipur
  • Erol Meerol Eigi Choirol
  • Ningol Chakouba organized at Delhi
  • The bare truth-the only truth :: Poem
  • Scientific freshwater prawn culture in NE
  • Equal footing for tribal population
  • Violence and conflict situation
  • Did Tribes Fight for Freedom of our Nation
  • COVID-19 Status 15 Nov : Govt of Manipur
  • Consultation: Protection of Rivers, Leimatak
  • Dr Naorem Bidyasagar- Bal Sahitya Puraskar
  • World Diabetes Day 2021
  • Padma awards now are more peoples' award
  • Bloodshed amid peace in state narrative
  • NE & Delhi: Bridging policy disconnect
  • Ningol Chakouba @ Thanga : Gallery
  • COVID-19 Status 14 Nov : Govt of Manipur
  • Nupana Khutlingba Samajda 'Nupa'
  • Through Her Eyes : Peace Festival of NE
  • Webinar on US Medical Licensing Exam
  • GMOs, is it a Yes or No?
  • Sobbing in solitude
  • Lesson learnt from ABP News-Cvoter survey
  • Glasgow Climate Pact, a step forward?
  • Ningol Chakkouba: origin & significance
  • COVID-19 Status 13 Nov : Govt of Manipur
  • Exhibition on Judicial Establishments
  • My namesake
  • Kidney patient must take fistula seriously
  • What to see & what to do at Kangla Fort
  • COVID-19 Status 12 Nov : Govt of Manipur
  • Meetei tribe bears more tribal characters..
  • Scholarship payment for OBC & SC students
  • Do you know ? :: Poem
  • COVAXIN data published in The Lancet
  • Disturbing vaccine hesitancy trend
  • Chinese village in Arunachal Pradesh
  • Online Teaching in a Pandemic World
  • COVID-19 Status 11 Nov : Govt of Manipur
  • State Level Moot-Court Competition
  • Ecological task force in Manipur #2
  • Makeup Competition - Lumiere 2021
  • Essential winter skin care tips
  • Inadequacy of women in decision making
  • Election under the shadow of Covid
  • Ningol Chakouba Shopping #1 : Gallery
  • COVID-19 Status 10 Nov : Govt of Manipur
  • Legal Services / Commendation Ceremony
  • Handloom & Handicraft of NE in Kolkata
  • Upcoming election: View on social auditing
  • Organic Farming
  • Task cut out for school, college
  • Rise of drug mafias: An impending challenge
  • Ningol Chakouba @ Itanagar : Gallery
  • COVID-19 Status 09 Nov : Govt of Manipur
  • Ningol Chakouba organized at Arunachal
  • Resolution: Climate Change in Manipur
  • Consultation on Climate Change in Manipur
  • Firecracker hub of Sivakasi in TN
  • Season of turncoats
  • Of defection and Assembly election
  • Ningol Chakouba @ Pune : Gallery
  • COVID-19 Status 08 Nov : Govt of Manipur
  • Quarantine Center Tamnalai : e-premiered
  • Discussion :: Youth & Electoral Politics -II
  • Ningol Chakouba organized at Pune
  • A new jurisprudence for political prisoners
  • Private sector shaping healthcare landscape
  • Preparation to tackle Covid spread during poll
  • Ching-Tam Ningol Chakouba : Gallery
  • COVID-19 Status 07 Nov : Govt of Manipur
  • The worth of my sweat :: Poem
  • Career in science for development
  • Despite India-China disputes, trade persist
  • Chronic shortage in fish production
  • The other parties too matter : NPP & NPF
  • Ningol Chakouba Fish Fair : Gallery
  • COVID-19 Status 06 Nov : Govt of Manipur
  • The Mindless Race for Marks
  • Ecological task force in Manipur #1
  • Plastic is a blessing in disguise
  • Ningols on way to her mapam: Gallery
  • COVID-19 Status 05 Nov : Govt of Manipur
  • Huidrom Nageshwar: Antarctica Expedition
  • Mera Thagi Sanarei :: Poem
  • 'La Decima'
  • Relief for common man on petrol price
  • Essence of Chakkouba triumphing over gift
  • Essence of Ningol Chakkouba
  • Kang Tournament @Pishum #2 : Gallery
  • COVID-19 Status 04 Nov : Govt of Manipur
  • Nambul Run 2021: conserve Nambul river
  • Reminiscences of bygone years 80s & 90
  • Goat farming: Enterprise for rural youth
  • Will scientific breakthroughs spur #endTB
  • Test & vaccination must be complementary
  • Start of big talks ahead of Assembly polls
  • Kwak Tanba @Sana Konung #3 : Gallery
  • COVID-19 Status 03 Nov : Govt of Manipur
  • Tiluck Keisham enters Guinness Record
  • Chief Ministerial candidates
  • Nostalgia :: Poem
  • Deepavali - childhood reminiscences
  • Surplus BJP ticket seekers
  • Scripting a situation for super spreader
  • Miss Chavang Kut Northeast 2021
  • COVID-19 Status 02 Nov : Govt of Manipur
  • Call for application for MFA 2021-22
  • Political Resolution : Naga settlement
  • Shattered glance of life :: Poem
  • 6th World Ayurveda Day
  • Being vegetarian - for healthy environment
  • Thriving wildlife in Kuilong forest
  • Rules are rules, better follow them!
  • Unity Ride @ Khoupum, Noney : Gallery
  • COVID-19 Status 01 Nov : Govt of Manipur
  • Loktak & Imphal Valley Landscape: Gallery
  • Clean India @Khumbong : Gallery
  • Mera Houchongba @ Kangla #2 : Gallery
  • Rakhesh Ksh : 2021 Stanford Univ's Top 2%
  • ZMlgdr AEKoIn :: Seireng
  • Bor khoiramnaba @Hiyangthang #3 : Gallery
  • Cosmos Festival @ Maram #2 : Gallery
  • Kwak Tanba @Sana Konung #2 : Gallery
  • Naga Peace Process :: News Timeline
  • Mera Houchongba @ Kangla #1 : Gallery
  • Abonmai: Shutdown- 4 Oct #3: Gallery
  • Bishwamitra Chongtham - Boxing: Gallery
  • Tarpon Katpa @ Loktak #1 : Gallery
  • Saikhom Mirabai: Olympics #2: Gallery
  • Manipur Olympians reception : Gallery
  • Mary Kom reception- Aug 20: Gallery
  • Hijam Gourashyam : Manipur Sahitya
  • Sushila Likmabam reception- Aug 18: Gallery
  • S Nilakanta / P Sushila [Aug 11] #2 : Gallery
  • S Nilakanta / P Sushila [Aug 11] #1 : Gallery
  • Mirabai felicitated truck drivers: Gallery
  • Saikhom Mirabai @Imphal #3: Gallery
  • Saikhom Mirabai @Imphal #2: Gallery
  • Saikhom Mirabai @ Kakching: Gallery
  • Shanglakpam Nilakanta: Olympics #2: Gallery
  • Sushila Pukhrambam :: Olympics : Gallery
  • Saikhom Mirabai : Tokyo Olympics 2020
  • Pukhrambam Sushila : Tokyo Olympics Dream
  • Sushila Likmabam: Olympics Dream: Gallery